Four Patents and a Time Machine: CareFirst and the Perils of Backdated Antitrust
Four patents can carry a lot of antitrust baggage—especially when they come tucked inside a portfolio of more than 500. In CareFirst of Maryland v. Johnson & Johnson, health insurer CareFirst alleges that Johnson & Johnson unlawfully acquired and later asserted four patents to delay competition from biosimilars, highly similar alternatives to biologic drugs, for ... Four Patents and a Time Machine: CareFirst and the Perils of Backdated Antitrust
The post Four Patents and a Time Machine: CareFirst and the Perils of Backdated Antitrust appeared first on Truth on the Market.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.